Wockhardt Gets Expert Panel Nod for Phase III Study of Recombinant Insulin Aspart Susmita Roy15 Dec 2025 2:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting permission to...
CDSCO Panel Seeks Revised Phase IV Study for Zydus' Empagliflozin, Metformin FDC Susmita Roy15 Dec 2025 1:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO), has asked Zydus Healthcare...
GLP-1 Receptor Agonists Use Linked to Reduced Vertebral Fracture Risk: JAMA Medha Baranwal15 Dec 2025 9:15 AM ISTTaiwan: A cohort study of individuals with type 2 diabetes (T2D) revealed that glucagon-like peptide 1 (GLP-1) receptor agonists were associated with...
Could GLP-1 drugs affect risk of epilepsy for people with diabetes? Dr. Kamal Kant Kohli12 Dec 2025 8:30 PM ISTA preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy....
Higher Community Climate Vulnerability Index Predicts Increased T2D Incidence: JAMA Dr Riya Dave12 Dec 2025 8:15 PM ISTResearchers have found in a cohort study of 1,003,526 adults that a higher community Climate Vulnerability Index is linked to an increased risk of...
Dual Metformin-GLP-1 Therapy Shows Major Reduction in Cancer Risk and Mortality: Study Dr Riya Dave12 Dec 2025 11:45 AM ISTAccording to a study published in Diabetes, Obesity and Metabolism, combining metformin with GLP-1 receptor agonists was linked to a 39% reduction in...
Healthy lifestyle combined with newer diabetes medications lowered CV risk, reveals research Dr. Kamal Kant Kohli11 Dec 2025 9:00 PM ISTPeople with Type 2 diabetes who combined healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) medications had a greater reduction in risk...
Hearing Loss Risk Over 4 Times Higher in People With Type 2 Diabetes: Meta-Analysis Medha Baranwal10 Dec 2025 8:30 PM ISTSpain: A new systematic review and meta-analysis has shed light on a frequently overlooked complication of type 2 diabetes mellitus (T2D): hearing...
Uncontrolled T2DM in India and Application of Trusted Molecules Empagliflozin, Sitagliptin, and Metformin Coming Together Dr. Sunil M Jain10 Dec 2025 11:13 AM ISTThe Growing Burden of Uncontrolled T2DM in India: The burden of diabetes in India has risen markedly, yet only around 7% of individuals with diagnosed...
Sweet tooth: How blood sugar migration in diabetes affects cavity development? Dr. Kamal Kant Kohli10 Dec 2025 11:00 AM ISTIndividuals with type 2 diabetes often have a higher incidence of tooth decay, but the underlying mechanisms remain unclear. Recent evidence indicates...
New fat-burning diabetes pill protects muscle and appetite, reports research Dr. Kamal Kant Kohli8 Dec 2025 8:00 PM ISTLowering blood sugar and increasing fat burning without reducing appetite or muscle mass is emerging as a promising possibility in the treatment of...
